Senator Ticked Off as Mylan (MYL) CEO Agrees to Speak at Industry Conference But Not Testify Before Congress
11/30/2016 6:14:48 AM
Heather Bresch is willing to participate in a high-profile industry conference this week, but not testify before Congress — and Sen. Chuck Grassley is miffed.
The Mylan Pharmaceuticals chief executive officer is scheduled to appear this coming Thursday at the Forbes Health Summit, a day-long event where high-ranking health industry types and investors assess the present and peer into the future. And Bresch is a featured participant: she’s agreed to chat for 30 minutes about the “public firestorm” over pricing for the EpiPen allergy device, according to the agenda.
comments powered by